SHANGHAI, Aug. 16, 2021 /PRNewswire/ — 111, Inc. (“111” or the “Enterprise”) (NASDAQ: YI), a primary tech-enabled healthcare system company dedicated to digitally connecting sufferers with medicine and healthcare products and services in China, these days declared the growth of its present partnership with Bayer Healthcare Co. Ltd. (“Bayer”).
111 and Bayer Healthcare 1st entered into a strategic partnership in September 2020, to collaborate on drug commercialization initiatives in China. Especially, 111 and Bayer agreed to function to the commercialization of revolutionary drugs and health care solutions for persistent condition administration, as properly as offering helpful sources for affected individual training. Leveraging 111’s broad community of pharmacies and health care providers facilitates the enlargement of Bayer’s presence in underserved markets in China, as properly as improves the major drug maker’s channel administration and affected person outreach abilities. The two corporations also agreed to jointly establish a electronic written content portal that supplies online pharmacist schooling, as effectively as interactive affected individual training, and other providers. The objective of this platform is to let sufferers, health care vendors, and pharmaceutical corporations to perform alongside one another to produce patient-centric health care management designs that emphasis on delivering top quality assistance, in a more effortless and considerably less restrictive way for the individual.
At the moment, 111 is the only e-commerce company in China to have secured a immediate sourcing partnership with Bayer. The new arrangement deepens this connection, as 111 will also assist Bayer with commercialization via proprietary technology, such as its Smart provide chain, major info, and cloud services. Increasing the partnership even now further, 111 will cover an elevated variety of impressive medicine for Bayer, as the two organizations will get the job done together to achieve bigger penetration in the broader on the net and offline marketplaces. Also growing is the range of therapeutic regions that 111 handles for Bayer, which now will encompass diabetic issues, oncology, cardiovascular, cerebral and gynecology. Eventually, the two events will leverage 111’s e-hospital abilities to assemble a illness administration platform to build a digital “health care + drugs” support design for patients such as health practitioner-individual conversation, disorder program management, and online and offline DTP delivery of medications.
111’s Co-Founder and Executive Chairman, Dr. YU Gang, commented, “We are quite happy with what Bayer and 111 have been capable to attain alongside one another by means of our partnership, and search forward to our continuing to innovate collectively in the location of health care. By leveraging our respective strengths and experience, the two providers will jointly discover additional effective health care supply models, advancing the traditional health care process to the modern-day period of electronic “healthcare + drugs” to provide folks in China with high-excellent products and hassle-free solutions, and to assistance construct a “healthy China“.”
Ms. LUO Xiaojie, Senior Vice President at Bayer Prescribed drugs, commented, “Whilst Bayer and 111 have by now formulated a mutually cooperative marriage, in several ways this settlement marks a new starting. It will greater allow the two functions to give complete engage in to their distinctive advantages in the medical and pharmaceutical fields, and the innovative digital services model will build benefit for the pharmaceutical field and profit more Chinese individuals.”
Bayer is a world enterprise with core competencies in the daily life science fields of health and fitness care and nourishment. Its items and providers are made to help people today and planet prosper by supporting efforts to grasp the significant worries presented by a escalating and ageing worldwide population. Bayer is fully commited to travel sustainable development and create a good effect with its enterprises. At the exact time, the Group aims to raise its earning ability and create price by way of innovation and development. The Bayer brand stands for belief, reliability and high quality during the world. In fiscal 2020, the Team used close to 100,000 people and experienced gross sales of 41.4 billion euros. R&D costs before particular objects amounted to 4.9 billion euros. For more data, go to www.bayer.com.
About 111, Inc.
111, Inc. (NASDAQ: YI) (“111” or the “Organization”) is a top tech-enabled healthcare system corporation fully commited to digitally connecting sufferers with medicine and healthcare providers in China. The Corporation gives individuals with much better access to pharmaceutical solutions and health care providers specifically as a result of its online retail pharmacy, 1 Pharmacy, and indirectly through its offline digital pharmacy community. The Enterprise also presents on the internet healthcare companies as a result of its web healthcare facility, 1 Clinic, which supplies individuals with price tag-effective and easy online session, digital prescription services, and patient administration services. In addition, the Company’s on the net system, 1 Medication Market, serves as a 1-end store for pharmacies to resource a wide collection of pharmaceutical merchandise. With the most significant virtual pharmacy community in China, 111 enables offline pharmacies to superior serve their buyers with cloud-centered solutions. 111 also provides an omni-channel drug commercialization system to its strategic companions, which includes providers these as electronic marketing and advertising, patient training, details analytics, and pricing checking.
For much more facts on 111, you should stop by: http://ir.111.com.cn/.
This press launch includes forward-seeking statements. These statements represent “ahead-wanting” statements within the which means of Portion 21E of the Securities Exchange Act of 1934, as amended, and as outlined in the U.S. Private Securities Litigation Reform Act of 1995. These ahead-looking statements can be recognized by terminology this sort of as “will,” “expects,” “anticipates,” “foreseeable future,” “intends,” “programs,” “believes,” “estimates,” “concentrate on,” “confident” and equivalent statements. Among the other points, the Small business Outlook and quotations from administration in this announcement, as properly as 111’s strategic and operational programs, incorporate ahead-wanting statements. 111 may possibly also make composed or oral forward-seeking statements in its periodic reports to the U.S. Securities and Exchange Fee, in its annual report to shareholders, in push releases and other composed supplies and in oral statements manufactured by its officers, administrators or workers to third parties. These kinds of statements are based mostly upon management’s latest expectations and existing sector and functioning conditions and relate to gatherings that entail recognized or unfamiliar pitfalls, uncertainties and other factors, all of which are hard to predict and a lot of of which are over and above the Firm’s regulate. Ahead-on the lookout statements entail inherent dangers, uncertainties and other factors that could induce actual success to differ materially from these contained in any such statements. Prospective risks and uncertainties consist of, but are not minimal to, uncertainties as to the Firm’s means comply with comprehensive and evolving regulatory specifications, its ability to contend properly in the evolving PRC basic health and fitness and wellness market, its potential to control the development of its organization and growth designs, its capability to reach or keep profitability in the foreseeable future, its means to regulate the risks connected with its pharmaceutical retail and wholesale firms, and the Firm’s potential to meet the standards essential to sustain listing of its ADSs on the Nasdaq International Market place, such as its means to heal any non-compliance with Nasdaq’s continued listing conditions. Additional facts pertaining to these and other threats, uncertainties or things is integrated in the Firm’s filings with the U.S. Securities and Trade Commission. All info furnished in this press launch is as of the day of this push launch, and 111 does not undertake any obligation to update any forward-searching statement as a result of new information, future occasions or if not, apart from as necessary below applicable law.
For far more details, remember to get hold of:
Mobile phone: +1 646-274-3580
E-mail: [email protected]
Cellular phone: +86-021-2053 6666 (China)
Email: [email protected]
Resource 111, Inc.